
NexgenRx Inc.
Share · CA65337X1042 (OTC)
No Price
Closing Price OTC 08.12.2025:
0,20 USD
08.12.2025 21:00
Current Prices from NexgenRx Inc.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
NEGXF
|
USD
|
08.12.2025 21:00
|
0,20 USD
| 0,00 USD |
Company Profile for NexgenRx Inc. Share
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers prescription drug claims; dental claims; and claims for the extended health benefits, as well as a health care spending account that provides an amount of money to an individual to pay for health or dental benefits. The company also offers individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; direct deposit services; and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
Company Data
Name NexgenRx Inc.
Company NexgenRx Inc.
Website
https://www.nexgenrx.com
Primary Exchange
UTC
ISIN CA65337X1042
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Plans
CEO Ronald C. Loucks
Market Capitalization 20 Mio
Country Canada
Currency USD
Employees -
Address 185 The West Mall, M9C 5L5 Toronto
IPO Date 2017-12-18
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | NEGXF |
More Shares
Investors who hold NexgenRx Inc. also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.


